A METHYLHYDRAZINE DERIVATIVE IN HODGKIN'S DISEASE AND OTHER MALIGNANT NEOPLASMS. THERAPEUTIC AND TOXIC EFFECTS STUDIED IN 51 PATIENTS.
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D001853:Bone Marrow; D001921:Brain; D004358:Drug Therapy; D006689:Hodgkin Disease; D006834:Hydrazines; D007970:Leukopenia; D008099:Liver; D008168:Lung; D008763:Methylhydrazines; D009369:Neoplasms / Q000628:therapy*; D010336:Pathology; D010600:Pharmacology; D013902:Radiography, Thoracic; D013921:Thrombocytopenia; D014116:Toxicology; D014747:Vinblastine
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D006834:Hydrazines; D008763:Methylhydrazines; D014747:Vinblastine
ALKYLATING AGENTS; ANTINEOPLASTIC AGENTS; BONE MARROW; BRAIN; DRUG THERAPY; HODGKIN'S DISEASE; HYDRAZINES; LEUKOPENIA; LIVER; LUNG; NEOPLASM THERAPY; PATHOLOGY; PHARMACOLOGY; THORACIC RADIOGRAPHY; THROMBOPENIA; TOXICOLOGIC REPORT; VINBLASTINE